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CASE 1
SP presented aged 13 with episodes of clonic jerking
of his left arm. His birth and early development
had been normal. There was no family history of
epilepsy, no febrile convulsions and no other special
risk factors for epilepsy. His first seizure occurred
without warning while in the classroom at school. He
noted vigorous jerking of his left hand and arm which
did not spread and lasted about 40 seconds. He did not
immediately seek medical advice, but following two
further episodes in the next few months he attended
his family doctor and was referred to a neurologist
elsewhere. A CT brain scan was normal and an EEG
showed a clear right frontal interictal epileptiform
disturbance. He was treated with phenytoin initially;
with seizures continuing every few weeks, sodium
valproate was added. Seizures were not controlled
and, aged 17, he was referred to our clinic. An
MRI brain scan showed a small lesion with low
signal on T1 which was felt to be compatible with
a low-grade tumour, dysembryoplastic neuroepithelial
tumour (DNET) or cortical dysplasia. He underwent
an unsuccessful trial of carbamazepine and subse-
quently surgery was planned. His typical habitual
seizure was recorded during video-EEG telemetry
showing a very clear right frontal onset. Prior to
surgery in 1994 he underwent H215O PET to study
the functional anatomy of his primary sensorimotor
cortex. Simple movements of the hand, shoulder and
face were alternated with rest. Analysis of these
data showed apparent activation of the lesion itself
during movement of the right hand, with no apparent
reorganization of the primary motor region in response
to the presence of the lesion. Experience with cortical
mapping by functional imaging was very limited at
that time, so SP underwent surgery with cortical
stimulation mapping while awake. This confirmed the
eloquent nature of the lesion and a small biopsy only
was carried out. This confirmed DNET. SP continues
under medical treatment only.
CASE 2
LR presented with complex partial and secondary
generalized seizures aged 8. She had been born
normally and although early milestones were normal
she was felt to be behind her peers at school but was
able to remain in normal schooling. She had no febrile
convulsions, no family history of epilepsy and no
special risk factors. Her first seizure occurred during
an argument in the playground at school. No good
account was provided of the onset but a staff member
found her lying on the ground in a generalized tonic–
clonic seizure. She recovered well and was reassured
by her family doctor. Six months later she had an
episode witnessed by her mother in which she became
suddenly quiet, pale and unresponsive. She swallowed
repeatedly, made a few incomprehensible sounds and
plucked at her clothes for about 1 minute. These
episodes became frequent over the next few years,
occurring up to five times per week. Very rarely these
episodes would evolve into a secondary generalized
tonic–clonic seizure. The features of her complex
partial seizures were rather variable and automatisms
were not always seen. Initially she responded well
to carbamazepine, but control was lost and not
regained despite trials of six anticonvulsants alone and
in combinations. She was referred aged 19 to our
service for consideration of surgery. An MRI brain
scan was normal, including hippocampal volumetry,
hippocampal and amygdala T2 signal mapping and
3D reconstruction for cortical surface rendering. PET
with the benzodiazepine ligand 11C-flumazenil was
undertaken. In comparison with a group of 17 normal
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controls and using statistical parametric mapping
(SPM) analysis, this showed significantly reduced
flumazenil binding in both mesial temporal lobes.
Video-EEG telemetry was undertaken; this showed
seizures which were not consistently lateralized and
which suggested mesial temporal onset. A further
period of telemetry was undertaken with bilateral
hippocampal depth electrodes. This revealed frequent
independent hippocampal interictal spikes and also
revealed onset of seizures occurring independently
from both hippocampi. Surgery was not undertaken
and LR remains under medical treatment.
CASE 3
AS presented aged 22 with complex partial seizures.
His birth, early development and past medical history
were unremarkable; he had no family history of
seizures or special risk factors. His first seizure
occurred without warning while at home watching
television. His partner noted that AS suddenly
became unresponsive, turned his head to the right,
blinked frequently and looked confused. The episode
lasted about 2 minutes and was followed by 20
minutes of confusion. Habitual seizures of this pattern
became established. He was referred to our clinic 3
years after onset. MRI brain was normal, including
hippocampal volumetry, hippocampal and amygdala
T2 signal mapping and 3D reconstruction for cortical
surface rendering. AS had been treated successively
with five anticonvulsants, alone and in combinations,
without marked improvement. He was considered
for surgical treatment. Video-EEG telemetry showed
frequent interictal epileptiform activity in the left pos-
terior temporal region; ictal onset was from this area.
He underwent 11C-flumazenil PET which, compared
with 17 controls, showed a sharply delineated 2 cm
diameter region of very markedly reduced flumazenil
binding in the left posterior temporal region. AS
underwent surgery using a 3D image navigation
system in which the PET dataset was coregistered
with MRI. Additionally, electrocorticography was
undertaken, which confirmed that the region of
reduced flumazenil binding showed very frequent
spiking. A small cortical resection was undertaken.
Histology showed typical focal cortical dysplasia
and the patient remains seizure-free after 14 months
follow-up.
COMMENTARY ON CASE REPORTS
These three cases, based on patients seen in our service
over the last few years, demonstrate some important
points. Firstly, case 1 illustrates the potential for
non-invasive functional imaging to delineate eloquent
functional regions with respect to the boundaries of a
proposed surgical resection. The functional imaging in
this case revealed that the lesion itself was eloquent, a
finding confirmed by intraperative cortical stimulation
mapping. Although unusual, preservation of function
in developmental lesions has been described (e.g.
Richardson, M. P., Koepp, M. J., Brooks, D. J.,
Coull, J., Grasby, P. et al. Cerebral activation in
malformations of cortical development. Brain 1998;
121: 1295–1304). Cases 2 and 3 illustrate the potential
for 11C-flumazenil PET to identify relevant pathology
in patients whose MRI studies have been normal.
In case 2, bilateral hippocampal seizure onset was
suggested by PET and confirmed with depth studies;
in case 3 a small neocortical lesion was identified and
successfully resected.
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Self-assessment questions
Question 1.
In the interpretation of a PET study:
(1) reference should always be made to structural imaging.
(2) FDG PET shows a clearly localized region of hypometabolism in most focal epilepsy subjects.
(3) FDG PET can be an important supplement to a normal MRI study.
(4) flumazenil PET has not been shown to have any advantage over structural MRI.
(5) imaging of the serotonin system may reveal epileptogenic tubers in tuberose sclerosis.
Question 2.
Functional magnetic resonance imaging of cognitive function:
(1) reveals language lateralization with most language paradigms.
(2) cannot be used in children.
(3) can be repeated without risk to the patient.
(4) reveals hippocampal memory function in epilepsy patients.
(5) has rendered the Wada test obsolete.
Question 3.
Magnetic resonance spectroscopy:
(1) has high spatial resolution.
(2) usually examines spectra related to 31P.
(3) when using 1H (proton) spectra, usually examines NAA, choline and creatine.
(4) unlike PET, cannot evaluate neurotransmitter systems.
(5) has not been applied to children.
Question 4.
The following statements reflect best pre-surgical practice:
(1) interictal SPECT is a useful approach in pre-surgical evaluation.
(2) SPECT is never of predictive value in pre-surgical evaluation.
(3) timing of the ictal SPECT injection is not critical.
(4) video-EEG at the time of ictal SPECT injection is important.
(5) ECD and HMPAO can be freely interchanged in studies of the same patient.
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Question 5.
Functional magnetic resonance imaging:
(1) identifies the origin of interictal epileptiform activity in most unselected subjects with epilepsy.
(2) cannot record the BOLD signal correlates of epileptic seizures.
(3) is compatible with continuous EEG recording.
(4) has identified neural networks subserving epileptiform activity.
(5) of spikes has never been compared with depth electrode recording.
Answers
Question 1.
In the interpretation of a PET study:
(1) true—the anatomical correlates of functional changes should always be examined.
(2) false—although many subjects may show a lateralized abnormality, hypometabolism is often extensive.
(3) true—an important role for FDG PET may be in the evaluation of potential surgical candidates with normal
MRI.
(4) false—flumazenil PET may reveal focal abnormalities in patients with normal MRI.
(5) true—this intriguing finding may prove clinically valuable.
Question 2.
Functional magnetic resonance imaging of cognitive function:
(1) false—finding a reliably lateralizing language paradigm has been very challenging.
(2) false—fMRI has been used widely in children.
(3) true—in contrast to PET and SPECT, there is no radiation risk, hence multiple studies for extensive cortical
mapping are possible.
(4) false—it has not yet proven possible to reliably activate the hippocampus in epilepsy patients.
(5) false—there is not yet sufficient data to regard fMRI as a substitute for the Wada test.
Question 3.
Magnetic resonance spectroscopy:
(1) false—relatively large voxels are required.
(2) false—usually examines spectra related to 1H.
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(3) true.
(4) false—spectral editing and modelling techniques are beginning to allow measurement of GABA and
glutamate.
(5) false.
Question 4.
The following statements reflect best pre-surgical practice:
(1) false—on its own, interictal SPECT is of very little value.
(2) false—the ictal-interictal coregistration technique SISCOM has been shown to be capable of prediction of
good outcome.
(3) false—the timing of the ictal SPECT injection is absolutely critical; late ictal injections may show very
different patterns from early ictal injection.
(4) true—the clinical and EEG features of the attack must be compared with the ictal SPECT findings.
(5) false—ECD and HMPAO have slightly different uptake patterns.
Question 5.
Functional magnetic resonance imaging:
(1) false—so far, only carefully selected subjects with frequent spikes generally provide a ‘positive’ finding.
(2) false—in seizures with minimal motor activity, the BOLD signal correlates of seizures may be recorded.
(3) true—although artefacts and safety issues need to be carefully addressed.
(4) true.
(5) false—a number of small comparative series have been described.
